Typhoid

20 registered clinical trials studyying Typhoid — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	ZyVac-TCV Bangladesh Study NCT06757283	International Centre for Diarrhoeal Disease Research, Bangladesh	Phase 3
Completed	Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid Fever NCT07150065	Avicenna Medical College Lahore	Phase 2
Unknown	Co-administration Study of OCV, TCV and MR NCT05771779	International Centre for Diarrhoeal Disease Research, Bangladesh	Phase 3
Completed	Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh NCT05475379	International Centre for Diarrhoeal Disease Research, Bangladesh	Phase 1 / Phase 2
Recruiting	Transcriptomic Responses for the Identification of Pathogens NCT04878549	University of Sheffield	—
Completed	Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III NCT04204096	International Vaccine Institute	Phase 3
Unknown	Immune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine NCT03933098	International Vaccine Institute	Phase 3
Completed	Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso NCT03614533	University of Maryland, Baltimore	Phase 2
Completed	Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine NCT03527355	International Vaccine Institute	Phase 2
Active Not Recruiting	Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blanty NCT03299426	University of Maryland, Baltimore	Phase 3
Completed	Effects of Aging on Primary and Secondary Vaccine Responses NCT03312699	Stanford University	Phase 1
Completed	Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine NCT02645032	International Vaccine Institute	Phase 1
Completed	A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines W NCT01466387	Novartis	Phase 3
Completed	Understanding Typhoid Disease After Vaccination NCT01405521	University of Oxford	Phase 2
Completed	Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults NCT00679172	Emergent BioSolutions	Phase 2
Completed	Studies of Immune Responses to Orally Administered Vaccines in Developing Country NCT01019083	International Centre for Diarrhoeal Disease Research, Bangladesh	Phase 1 / Phase 2
Completed	Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever NCT00125008	International Vaccine Institute	Phase 4
Completed	Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam NCT00131820	International Vaccine Institute	Phase 4
Completed	Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China NCT00131833	International Vaccine Institute	Phase 4
Completed	Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood NCT00125047	International Vaccine Institute	Phase 4